✦ LIBER ✦

Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

✍ Scribed by Okano, T.; Kondo, T.; Fujii, K.; Nishimura, T.; Takano, T.; Ohe, Y.; Tsuta, K.; Matsuno, Y.; Gemma, A.; Kato, H.; Kudoh, S.; Hirohashi, S.

Book ID: 127198194
Publisher: American Association for Cancer Research
Year: 2007
Tongue: English
Weight: 270 KB
Volume: 13
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-06-1654

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ZD1839 (Gefitinib, ‘Iressa’), an epiderm

ZD1839 (Gefitinib, ‘Iressa’), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma

✍ Fuminori Teraishi; Shunsuke Kagawa; Takanori Watanabe; Yasuhisa Tango; Takeshi K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 444 KB

829 The epidermal growth factor receptor

829 The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘iressa’, ZD-1839) and the protein prenyltransferase inhibitor M365408 as potential therapeutics in bladder cancer

✍ J.L. Dominguez-Escrig; J. Kelly; B.R. Davies 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Ocular findings in patients with solid t

Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Phase I and II clinical trials

✍ Murray, P I; Bristow, E; Forsythe, B J; Faulkner, K; Tullo, A B; Esmaeli, B 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 187 KB

ChemInform Abstract: Studies Leading to

ChemInform Abstract: Studies Leading to the Identification of ZD1839 (Iressa): An Orally Active, Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Targeted to the Treatment of Cancer.

✍ Keith H. Gibson; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 2 views

Gefitinib (‘Iressa’, ZD1839), an epiderm

Gefitinib (‘Iressa’, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines

✍ Satoru Shintani; Chunnan Li; Mariko Mihara; Junya Yano; Nagaaki Terakado; Koh-ic 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 508 KB

Gefitinib (‘Iressa’), an epidermal growt

Gefitinib (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells

✍ Satoru Shintani; Chunnan Li; Mariko Mihara; Koh-ichi Nakashiro; Hiroyuki Hamakaw 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 239 KB